The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter
David A. Katzenstein, Scott M. Hammer, Michael D. Hughes, Holly Gundacker, J. Brooks Jackson, Susan Fiscus, Suraiya Rasheed, Tarek Elbeik, Richard Reichman, Anthony Japour, Thomas C. Merigan, Martin S. Hirsch
Dive into the research topics of 'The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter'. Together they form a unique fingerprint.